DSS, Inc. Announces Launch of Proposed Public Offering

Rhea-AI Summary

DSS (NYSE: DSS) announced a proposed public offering of its common stock to be sold by the company, with net proceeds intended for general corporate and working capital purposes. The offering is subject to market conditions and may not be completed on a specific timeline or at specific terms.

Aegis Capital Corp. is sole book-running manager on a firm commitment basis. The offering will be made under an effective shelf registration statement (Form S-3 No. 333-281974, declared effective Nov 5, 2024), and a final prospectus supplement and accompanying prospectus will be filed with the SEC.

Positive

• Access to cash for general corporate and working capital needs
• Sole book-runner secured: Aegis Capital Corp. on firm commitment
• Offering covered by effective Form S-3 shelf registration

Negative

• Potential shareholder dilution from issuance of new common stock
• Completion, size, and terms are uncertain and market-dependent
• No specified proceeds amount or timetable disclosed

News Market Reaction – DSS

-32.37% 3.2x vol

18 alerts

-32.37% News Effect

+26.7% Peak Tracked

-21.6% Trough Tracked

-$6M Valuation Impact

$13M Market Cap

3.2x Rel. Volume

On the day this news was published, DSS declined 32.37%, reflecting a significant negative market reaction. Argus tracked a peak move of +26.7% during that session. Argus tracked a trough of -21.6% from its starting point during tracking. Our momentum scanner triggered 18 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $6M from the company's valuation, bringing the market cap to $13M at that time. Trading volume was very high at 3.2x the daily average, suggesting heavy selling pressure.

Data tracked by StockTitan Argus on the day of publication.

Market Reality Check

Price: $0.9975 Vol: Volume 543,032 is 2.6x th...

high vol

$0.9975 Last Close

Volume Volume 543,032 is 2.6x the 20-day average of 209,155, indicating elevated trading ahead of the offering. high

Technical Price at $1.39 is trading above the 200-day MA of $1.06, reflecting a pre-news uptrend and proximity to the $1.895 52-week high.

Peers on Argus

While DSS was up 17.8% before the offering news, sector peers in packaging/conta...

1 Up 3 Down

While DSS was up 17.8% before the offering news, sector peers in packaging/containers showed mixed moves, with several names in momentum scanners moving down (sector median about -6.0%). This points to company-specific dynamics rather than a broad sector move.

Market Pulse Summary

The stock dropped -32.4% in the session following this news. A negative reaction despite positive pr...

Analysis

The stock dropped -32.4% in the session following this news. A negative reaction despite positive price momentum earlier in the day would fit a typical pattern for dilutive equity offerings, especially when all shares are sold by the company for general corporate and working capital purposes. With DSS trading above its $1.06 200-day moving average and near its $1.895 52-week high, investors could reassess valuation against the increased share supply.

Key Terms

public offering, common stock, book-running manager, firm commitment basis, +4 more

8 terms

public offering financial

"today announced that it has commenced a public offering to offer and sell shares"

A public offering is when a company sells shares to the general public through the stock market, either by issuing new shares to raise cash or by letting existing owners sell their stakes. Think of it like a business opening its doors to many new owners at once: it can bring in money for growth but also increases the number of shares available, which can change the stock price and dilute existing ownership — key factors investors watch closely.

common stock financial

"offer and sell shares of its Common Stock. All of the shares of Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

book-running manager financial

"Aegis Capital Corp. is acting as the sole book-running manager for the offering"

A book-running manager is the lead organizer responsible for coordinating a large financial sale, such as issuing new stocks or bonds. They oversee preparing all necessary documents, setting the sale’s price, and finding buyers, much like a concert promoter arranging a major event. Their role matters to investors because they help ensure the offering is successfully sold at the best possible terms.

firm commitment basis financial

"book-running manager for the offering on a firm commitment basis."

An agreement in which an underwriter agrees to buy an entire new stock or bond offering from a company and then resell it to the public, taking full responsibility for any unsold shares. Think of the underwriter as a store that buys all the inventory up front: this guarantees the company gets the money and gives investors certainty the deal will happen, while the underwriter’s risk and pricing choices can affect short‑term share availability and price stability.

shelf registration statement regulatory

"The offering is being made pursuant to an effective shelf registration statement"

A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.

form s-3 regulatory

"effective shelf registration statement on Form S-3 (No. 333-281974)"

Form S-3 is a legal document companies use to register their stock sales with the government, making it easier and faster for them to raise money by selling shares to investors. It’s like having a pre-approved shopping list that lets a company quickly sell new shares when they need funds, without going through a lengthy approval process each time.

prospectus supplement regulatory

"A final prospectus supplement and accompanying prospectus describing the terms"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

prospectus regulatory

"final prospectus supplement and accompanying prospectus describing the terms"

A prospectus is a detailed document that explains a company's plans for offering new shares or investments to the public. It’s important because it provides potential investors with key information about the company’s business, risks, and how they might make money, helping them decide whether to invest. Think of it as a guidebook for understanding what you're buying into.

AI-generated analysis. Not financial advice.

NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE: DSS) (the “Company”), a multinational company operating across diverse industries including packaging, wealth management, and biohealth innovation, today announced that it has commenced a public offering to offer and sell shares of its Common Stock.

All of the shares of Common Stock are being offered by the Company (the “Offering”).

The Company intends to use the net proceeds from the Offering for general corporate and working capital needs. The Company’s Common Stock is trading on the NYSE American LLC under the symbol “DSS”. The Offering is subject to market conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.

Aegis Capital Corp. is acting as the sole book-running manager for the offering on a firm commitment basis.

The offering is being made pursuant to an effective shelf registration statement on Form S-3 (No. 333-281974) previously filed with the U.S. Securities and Exchange Commission (SEC) on October 31, 2024, and declared effective by the SEC on November 5, 2024. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC’s website located at www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Aegis Capital Corp., Attention: Syndicate Department, 1345 Avenue of the Americas, 27th floor, New York, NY 10105, by email at syndicate@aegiscap.com, or by telephone at +1 (212) 813-1010.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About DSS, Inc.

DSS, Inc. is a multinational company operating across multiple business lines including health and wellness, packaging, real estate, and securities and blockchain. The Company operates a business model based on developing high-growth subsidiaries and unlocking value through strategic IPOs and public listings. For more information, visit www.dssworld.com.

Forward-Looking Statements

The foregoing material may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation statements regarding the Company’s product development and business prospects, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of risks and uncertainties that could significantly affect current plans. Should one or more of these risks or uncertainties materialize, or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the security laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

For investor and media inquiries or additional information, please contact:

Investor Contact:
DSS, Inc.
Investor Relations
ir@dssworld.com
+1 (585) 565-2422

FAQ

What did DSS (DSS) announce on February 4, 2026 about a public offering?

DSS announced it commenced a proposed public offering of common stock for corporate and working capital needs. According to the company, the offering is subject to market conditions and may not be completed or priced as currently contemplated.

Who is managing the DSS (DSS) public offering and on what basis?

Aegis Capital Corp. is the sole book-running manager on a firm commitment basis. According to the company, Aegis will handle syndicate and distribution activities for the proposed offering.

Will DSS (DSS) use a shelf registration for the proposed offering?

Yes, the offering will be made under an effective Form S-3 shelf registration (No. 333-281974). According to the company, the registration was declared effective by the SEC on November 5, 2024.

How will DSS (DSS) use proceeds from the proposed offering?

Proceeds are intended for general corporate purposes and working capital. According to the company, no specific allocation, amount, or timetable for using proceeds was disclosed in the announcement.

Where can investors find the final prospectus for the DSS (DSS) offering?

The final prospectus supplement and accompanying prospectus will be filed with the SEC and available on SEC.gov. According to the company, electronic copies will also be available from Aegis Capital syndicate contacts when released.